Project Grant R35GM165843
- This Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports a research project titled "OPUS: Synthesizing Theory and Data in the Ecology of Zoonotic Diseases: A Multi-System Perspective". The $298,354 award from January 1, 2025 to December 31, 2026 will enable the University of Georgia Research Foundation, Inc. to create a comprehensive database and online portal integrating data from various NSF-funded studies on emerging...
- The National Science Foundation Division of Emerging Frontiers awarded the University of Georgia Research Foundation a $1,000,000 Project Grant under the Biological Sciences (CFDA 47.074) federal grant program. The grant funds the PIPP PHASE I: HETEROGENEOUS MODEL INTEGRATION FOR INFECTIOUS DISEASE INTELLIGENCE project from August 1, 2022 to January 31, 2024. The project aims to develop a systems-of-systems framework to integrate knowledge from different disciplinary approaches for infectious...
- Federal Project Grant Award Summary The Trustees of Columbia University in the City of New York, Health Sciences Division, received a $2,056,250 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2029. This four-year award funds the development of novel computational tools and methodologies for early detection and inference of emerging...
- This $195,101 Project Grant, awarded by the National Science Foundation's (NSF) Biological Sciences program (CFDA 47.074), will use mathematical modeling to project the healthcare burden associated with COVID-19, influenza, and respiratory syncytial virus (RSV) in the United States during the 2023-2024 respiratory virus season. The research will integrate estimates of population immunity from prior infections, vaccinations, and monoclonal antibody therapy to produce four rounds of projections...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Wisconsin–Madison a Project Grant of $422,814 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 25, 2025, with a completion date of May 31, 2027. The award funds the development and application of adversarial machine learning methods to predict viral spillover risk—specifically, to identify which animal viruses are likely to infect humans and...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $805,866 to the University of Georgia Research Foundation, Inc. under the Allergy and Infectious Diseases Research program (CFDA 93.855) on May 12, 2026, with a completion date of April 30, 2031. This project grant funds the development and validation of advanced predictive models designed to improve understanding of influenza vaccine response variability across diverse populations....
- This $1,999,688 National Science Foundation Project Grant supports the development of predictive intelligence for pandemic prevention through transdisciplinary innovation. Funded by NSF's Computer and Information Science and Engineering program (CFDA #47.070), the two-year award to the University of California, Davis enables advancement of predictive capabilities for forecasting pandemic risk through three key research areas. First, the team will characterize environmental conditions and human...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Georgia Research Foundation, Inc. a $228,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period July 1, 2026 through June 30, 2028. The project, titled "Parasite Glycosylphosphatidylinositol Libraries: Expanding the Toolbox for Parasite Glycobiology," focuses on developing enzymatic pipelines and modular...
- This five-year, $2.94 million Project Grant from the National Science Foundation's Biological Sciences program (CFDA 47.074) supports research at Cornell University to understand the mechanisms by which land use change triggers zoonotic pathogen spillover from wildlife to humans. The grant funds an interdisciplinary team to apply convergent biological, computational, and social science approaches to identify the "rules of emergence" driving land use-induced spillover of bat-borne...
- This Project Grant award from the National Science Foundation (NSF) Division of Mathematical Sciences, CFDA 47.049 Mathematical and Physical Sciences, provides $265,000 in funding to the University of Missouri at Kansas City (UMKC) from September 1, 2023 to August 31, 2026. The project aims to enhance mathematical models to investigate the influences of climate change on zoonotic disease transmission, or the transmission of infectious diseases from animals to humans. The research team will use...
This Project Grant award of $393,673, obligated on July 16, 2026, and funded through the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859), supports the development of a comprehensive, predictive framework for zoonotic disease emergence. The University of Georgia Research Foundation will conduct research spanning the full cascade from wildlife epizootics to human spillover and outbreak amplification. The project integrates large-scale host-virus networks, ecological and demographic data, and advanced statistical and machine learning approaches to identify ecological drivers of wildlife disease outbreaks, estimate hidden viral burdens across animal host taxa, and quantify spillover and amplification risk through a novel standardized epidemic potential parameter. Deliverables include agent-based models, predictive risk maps, and early-warning tools validated against influenza and coronavirus datasets. The research addresses a critical gap in pandemic preparedness by explicitly linking animal health measures with human disease risk forecasts, moving beyond siloed, single-pathogen approaches to create an integrated One Health framework. The award extends through May 31, 2031, enabling the research team to generate actionable scientific products that improve forecasting accuracy and support more proactive pandemic prevention strategies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $393.7k | 7/16/26 |